Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 043876/0230 | |
| Pages: | 5 |
| | Recorded: | 10/16/2017 | | |
Attorney Dkt #: | O046-0018USC1 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
2
|
|
Patent #:
|
|
Issue Dt:
|
09/06/2016
|
Application #:
|
14600958
|
Filing Dt:
|
01/20/2015
|
Publication #:
|
|
Pub Dt:
|
07/21/2016
| | | | |
Title:
|
MODULATION OF KCNH2 ISOFORM EXPRESSION BY OLIGONUCLEOTIDES AS A THERAPEUTIC APPROACH FOR LONG QT SYNDROME
|
|
|
Patent #:
|
|
Issue Dt:
|
05/01/2018
|
Application #:
|
15230718
|
Filing Dt:
|
08/08/2016
|
Publication #:
|
|
Pub Dt:
|
11/24/2016
| | | | |
Title:
|
MODULATION OF KCNH2 ISOFORM EXPRESSION BY OLIGONUCLEOTIDES AS A THERAPEUTIC APPROACH FOR LONG QT SYNDROME
|
|
Assignee
|
|
|
3181 SW SAM JACKSON PARK RD |
PORTLAND, OREGON 97239 |
|
Correspondence name and address
|
|
C. RACHAL WINGER, PH.D.
|
|
601 W. RIVERSIDE AVE.
|
|
SUITE 1400
|
|
SPOKANE, WA 99201
|
Search Results as of:
03/29/2024 09:42 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|